ISMPP Highlights
New Ethics Case Studies Present Insights on Common Publication Dilemmas
The ISMPP Ethics and Standards Committee is excited to announce 4 new case studies that present common dilemmas in the publication process and walk through the thought process for how one might arrive at possible resolutions…
Progress Towards a Reporting Guideline for Consensus-based Research: An Update from ACCORD
Following robust preparatory work, a Delphi process is underway to validate and refine a reporting guideline for consensus-based research, titled ACCORD (ACcurate COnsensus Reporting Document)…
GPP 2022 Published in Annals of Internal Medicine
The GPP4 Steering Committee (SC) and ISMPP are excited to announce the publication of the updated Good Publication Practice guidelines (GPP 2022) for company-sponsored research in Annals of Internal Medicine. Access GPP 2022 in the August 30, 2022 issue of Annals…
Message from Our Leadership
Robert J. Matheis
ISMPP President and CEO
News and Trends
Publications Without Borders – Harmonizing Local and Global Planning
Pharma-sponsored publications add to the evidence base and play a crucial role in various activities, including medical education, medical information, marketing, pricing and market access, and regulatory affairs. They also ensure timeliness of transparent data disclosure. At the local level, publications primarily serve specific needs, such as reimbursement activities, filling evidence gaps, or guiding local clinical practice…
Data Visualization: Call to Action for Publication Professionals
Data visualization in peer-reviewed publications is a powerful way to communicate science to broad audiences. When used effectively, data visualization can make information easier to understand and remember, thereby increasing the likelihood of data being used to guide clinical practice with evidence-based decisions…
“They Said What?” Recommendations for Capturing the Voice of Authors in Asia Pacific Region
Just as people have learning styles that vary between individuals, societal norms can vary significantly between cultures. Publication professionals operating in North America or Europe may not be aware of how their communications norms and preferences differ from those of their peers and authors based in APAC…
What Would You Do?
In our role as medical publication professionals, we may occasionally encounter situations in which it is not obvious how to ensure good publication practice. Have you ever wished you could consult the ISMPP membership for guidance when these situations arise? Here’s your opportunity!
What Would You Do? is a section of The MAP that presents case scenarios as an educational tool for medical publication professionals. The section provides a case scenario to ponder, and readers are invited to participate in a poll by selecting one of the listed solutions. Readers can also submit their thoughts on the scenario anonymously. The poll results, plus educational insights, are posted in a later issue for readers to digest.
Adverse Event Inclusion Just Before Abstract Submission
A medical writer worked with authors to develop a congress abstract for a Phase 2 clinical study. Two days before submission, the lead author requests an additional ‘medical narrative’ statement to be added detailing the management steps and time to resolution of an adverse event seen in one patient. What would you do?
ISMPP (pronounced IzMap) is the only nonprofit organization founded by medical publication professionals for medical publication professionals